The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jan 20, 2026 | Zdraveski Zoran | See Remarks | Grant(A) | 350K | — | $0 |
| Jan 20, 2026 | Louis Chrystal | Chief Medical Officer | Grant(A) | 420K | — | $0 |
| Jan 20, 2026 | Dworak Leiden | See Remarks | Grant(A) | 100K | — | $0 |
| Jan 20, 2026 | MacBeath Gavin | Chief Executive Officer, Director | Grant(A) | 1.2M | — | $0 |
| Jan 20, 2026 | Amello Jason | Chief Financial Officer | Grant(A) | 350K | — | $0 |
| Dec 23, 2025 | Lynx1 Capital Management LP | 10% Owner | Buy(P) | 6K | $0.90 | $6K |
| Dec 22, 2025 | Lynx1 Capital Management LP | 10% Owner | Buy(P) | 76K | $0.90 | $68K |
| Dec 19, 2025 | Lynx1 Capital Management LP | 10% Owner | Buy(P) | 80K | $0.90 | $72K |
| Jun 30, 2025 | Gruia Gabriela | Director | Grant(A) | 67K | — | $0 |
| Jun 30, 2025 | Dorton Katina | Director | Grant(A) | 67K | — | $0 |
| Jun 30, 2025 | Woods Keith | Director | Grant(A) | 67K | — | $0 |
| Jun 30, 2025 | Nicholson Garry A | Director | Grant(A) | 67K | — | $0 |
| Jun 30, 2025 | Klencke Barbara | Director | Grant(A) | 67K | — | $0 |
| Jun 30, 2025 | 667, L.P. | Director | Grant(A) | 67K | — | $0 |
| Jun 30, 2025 | 667, L.P. | Director | Grant(A) | 67K | — | $0 |
| May 20, 2025 | Lynx1 Capital Management LP | 10% Owner | Buy(P) | 1.2M | $1.20 | $1.4M |
| May 19, 2025 | Lynx1 Capital Management LP | 10% Owner | Buy(P) | 1.4M | $1.20 | $1.7M |
| Jan 3, 2025 | Louis Chrystal | Chief Medical Officer | Grant(A) | 400K | — | $0 |
| Jan 3, 2025 | Amello Jason | Chief Financial Officer | Grant(A) | 270K | — | $0 |
| Jan 3, 2025 | MacBeath Gavin | Chief Executive Officer, Director | Grant(A) | 800K | — | $0 |
| Jan 3, 2025 | Zdraveski Zoran | See Remarks | Grant(A) | 250K | — | $0 |
| Dec 26, 2024 | Nichols Weston | 10% Owner | Buy(P) | 7.5M | $4.00 | $30.0M |
| Dec 13, 2024 | Nichols Weston | 10% Owner | Buy(P) | 100K | $2.90 | $290K |
| Dec 12, 2024 | Nichols Weston | 10% Owner | Buy(P) | 32K | $3.01 | $96K |
| Nov 15, 2024 | Nichols Weston | 10% Owner | Buy(P) | 947 | $4.34 | $4K |
| Sep 23, 2024 | Klencke Barbara | Director | Buy(P) | 5K | $5.29 | $26K |
| Aug 26, 2024 | Klencke Barbara | Director | Buy(P) | 5K | $5.53 | $28K |
| Aug 23, 2024 | Zdraveski Zoran | See Remarks | Sell(S) | 165K | $5.78 | $952K |
| Aug 23, 2024 | Zdraveski Zoran | See Remarks | Option exercise(M) | 64K | $2.49 | $160K |
| Aug 23, 2024 | Zdraveski Zoran | See Remarks | Option exercise(M) | 13K | $1.81 | $24K |
| Aug 23, 2024 | Zdraveski Zoran | See Remarks | Option exercise(M) | 25K | $3.27 | $82K |
| Aug 23, 2024 | Zdraveski Zoran | See Remarks | Option exercise(M) | 55K | $4.85 | $266K |
| Aug 23, 2024 | Zdraveski Zoran | See Remarks | Option exercise(M) | 64K | — | $0 |
| Aug 23, 2024 | Zdraveski Zoran | See Remarks | Option exercise(M) | 25K | — | $0 |
| Aug 23, 2024 | Zdraveski Zoran | See Remarks | Option exercise(M) | 55K | — | $0 |
| Aug 23, 2024 | Zdraveski Zoran | See Remarks | Option exercise(M) | 13K | — | $0 |
| Aug 23, 2024 | Klencke Barbara | Director | Buy(P) | 5K | $5.69 | $28K |
| Jun 12, 2024 | Baker Bros. Advisors LP | Director | Grant(A) | 48K | — | $0 |
| Jun 12, 2024 | Baker Bros. Advisors LP | Director | Grant(A) | 48K | — | $0 |
| Jun 12, 2024 | Nicholson Garry A | Director | Grant(A) | 24K | — | $0 |
| Jun 12, 2024 | Nicholson Garry A | Director | Grant(A) | 48K | — | $0 |
| Jun 12, 2024 | Gruia Gabriela | Director | Grant(A) | 48K | — | $0 |
| Jun 12, 2024 | Klencke Barbara | Director | Grant(A) | 48K | — | $0 |
| Jun 12, 2024 | Dorton Katina | Director | Grant(A) | 48K | — | $0 |
| Jun 12, 2024 | Woods Keith | Director | Grant(A) | 48K | — | $0 |
| May 1, 2024 | Louis Chrystal | Chief Medical Officer | Grant(A) | 380K | — | $0 |
| Apr 19, 2024 | Lynx1 Capital Management LP | 10% Owner | Buy(P) | 5.0M | $7.13 | $35.6M |
| Apr 19, 2024 | 667, L.P. | Director | Buy(P) | 826K | $7.13 | $5.9M |
| Apr 19, 2024 | 667, L.P. | Director | Buy(P) | 8.9M | $7.13 | $63.1M |
| Feb 1, 2024 | Amello Jason | Chief Financial Officer | Grant(A) | 750K | — | $0 |
| Jan 12, 2024 | MacBeath Gavin | Chief Executive Officer, Director | Grant(A) | 160K | — | $0 |
| Jan 12, 2024 | Dworak Leiden | Insider | Grant(A) | 47K | — | $0 |
| Jan 12, 2024 | Zdraveski Zoran | See Remarks | Grant(A) | 53K | — | $0 |
| Dec 19, 2023 | Barberich Timothy J | Director | Buy(P) | 317 | $4.97 | $2K |
| Dec 18, 2023 | Barberich Timothy J | Director | Buy(P) | 29K | $4.89 | $141K |
| Dec 14, 2023 | Klencke Barbara | Director | Buy(P) | 5K | $5.08 | $25K |
| Dec 6, 2023 | Woods Keith | Director | Grant(A) | 18K | — | $0 |
| Jul 21, 2023 | Dworak Leiden | Chief Accounting Officer | Grant(A) | 25K | — | $0 |
| Jun 13, 2023 | Barberich Timothy J | Director | Grant(A) | 35K | — | $0 |
| Jun 13, 2023 | Barton Debora | Chief Medical Officer | Grant(A) | 430K | — | $0 |
| Jun 13, 2023 | Dorton Katina | Director | Grant(A) | 35K | — | $0 |
| Jun 13, 2023 | Gruia Gabriela | Director | Grant(A) | 35K | — | $0 |
| Jun 13, 2023 | Klencke Barbara | Director | Grant(A) | 37K | — | $0 |
| Jun 13, 2023 | Silver Brian M. | Chief Financial Officer | Grant(A) | 633K | — | $0 |
| Jun 13, 2023 | MacBeath Gavin | Chief Executive Officer, Director | Grant(A) | 1.1M | — | $0 |
| Jun 13, 2023 | Zdraveski Zoran | Chief Legal Officer | Grant(A) | 430K | — | $0 |
| Jun 2, 2023 | Barberich Timothy J | Director | Buy(P) | 38K | $2.63 | $100K |
| May 31, 2023 | Lynx1 Capital Management LP | 10% Owner | Sell(S) | 15K | $2.52 | $38K |
| May 31, 2023 | Lynx1 Capital Management LP | 10% Owner | Sell(S) | 10K | $2.51 | $25K |
| May 31, 2023 | Lynx1 Capital Management LP | 10% Owner | Sell(S) | 400 | $2.51 | $1K |
| Apr 6, 2023 | Klencke Barbara | Director | Grant(A) | 9K | — | $0 |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).